Chuck Wakefield Patient

Chuck is our “media darling” as he is a 73 yr. old patient who takes on incredibly difficult endeavors on behalf of the MMRF. His first event with us was climbing Kilimanjaro at the age of 70 and then did the full cross country R2V ride last fall. “I am a patient, first diagnosed with MM on routine physical exam in December 2003, with a rapidly developing case. The initial outlook wasn’t that great, and I had 8 months of intensive chemo, followed by a bone marrow transplant in August 2004. With a brand new immune system, I was 12 years old August 12, 2016, and am miraculously in complete remission for the past year and a half.”

I’m one of the Lucky Ones
Chuck Wakefield
I'm mindful of how many myeloma patients are having a tough time. I am one of the lucky ones.
Read More
The Multiple Myeloma Research Foundation (MMRF) is the largest nonprofit in the world solely focused on accelerating a cure for each and every multiple myeloma patient. We drive the development and delivery of next-generation therapies, leverage data to identify optimal and more personalized treatment approaches, and empower myeloma patients and the broader community with information and resources to extend their lives. Central to our mission is our commitment to advancing health equity so that all myeloma patients can benefit from the scientific and clinical advances we pursue. Since our inception, the MMRF has committed over $500 million for research, opened nearly 100 clinical trials, and helped bring 15+ FDA-approved therapies to market, which have tripled the life expectancy of myeloma patients. To learn more, visit

Learn More

At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity.

Learn more About Johnson & Johnson inovative medicine Learn more About Johnson & Johnson Follow us on @JanssenUS And @JNJInnovMed